GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » Total Liabilities

Alfresa Holdings (Alfresa Holdings) Total Liabilities : $7,194 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Alfresa Holdings Total Liabilities?

Alfresa Holdings's Total Liabilities for the quarter that ended in Dec. 2023 was $7,194 Mil.

Alfresa Holdings's quarterly Total Liabilities increased from Jun. 2023 ($6,432.01 Mil) to Sep. 2023 ($6,497.78 Mil) and increased from Sep. 2023 ($6,497.78 Mil) to Dec. 2023 ($7,193.79 Mil).

Alfresa Holdings's annual Total Liabilities declined from Mar. 2022 ($7,017.86 Mil) to Mar. 2023 ($6,370.57 Mil) but then increased from Mar. 2023 ($6,370.57 Mil) to Mar. 2024 ($6,459.59 Mil).


Alfresa Holdings Total Liabilities Historical Data

The historical data trend for Alfresa Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings Total Liabilities Chart

Alfresa Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,142.88 7,605.41 7,017.86 6,370.57 6,459.59

Alfresa Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,370.57 6,432.01 6,497.78 7,193.79 6,459.59

Alfresa Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alfresa Holdings's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6053.915+(222.749+128.502
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+54.426)
=6,460

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=9662.519-3202.927
=6,460

Alfresa Holdings's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6785.212+(208.36+144.067
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+56.146)
=7,194

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=10418.797-3225.012
=7,194

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alfresa Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Alfresa Holdings (Alfresa Holdings) Business Description

Traded in Other Exchanges
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines